These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1738921)

  • 1. Prolongation of cardiac allograft survival in rats by anti-TNF and cyclosporine combination therapy.
    Bolling SF; Kunkel SL; Lin H
    Transplantation; 1992 Feb; 53(2):283-6. PubMed ID: 1738921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival.
    Lin H; Wei RQ; Bolling SF
    J Surg Res; 1993 Oct; 55(4):441-5. PubMed ID: 8412131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporine A and methotrexate on induction of tumour necrosis factor-alpha in rat cardiac allografts.
    Ciesielski CJ; Mei J; Neton JT; Piccinini LA
    Transpl Immunol; 1997 Mar; 5(1):25-34. PubMed ID: 9106331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of low-dose cyclosporine A/methotrexate to prolong rat cardiac allograft survival.
    Pizarro TT; Malinowska K; Kovacs EJ; Clancy J; Robinson JA; Piccinini LA
    Transpl Immunol; 1993; 1(4):262-9. PubMed ID: 8081782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats.
    Harrison PC; Madwed JB
    J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.
    Imagawa DK; Millis JM; Seu P; Olthoff KM; Hart J; Wasef E; Dempsey RA; Stephens S; Busuttil RW
    Transplantation; 1991 Jan; 51(1):57-62. PubMed ID: 1987706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine.
    Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat.
    Lin H; Chensue SW; Strieter RM; Remick DG; Gallagher KP; Bolling SF; Kunkel SL
    J Heart Lung Transplant; 1992; 11(2 Pt 1):330-5. PubMed ID: 1576139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.
    Bolling SF; Lin H; Wei RQ; Linsley P; Turka LA
    J Surg Res; 1994 Jul; 57(1):60-4. PubMed ID: 8041150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of combined application of external cyclosporine A and CTLA4Ig on the survival of rat auricle allograft].
    Cao C; Li SR; Sun ZC; Wang ZX; Luo GX; Wu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jul; 16(4):281-3. PubMed ID: 12181799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences.
    Miyagawa S; Stepkowski SM; Lawen JG; Rutzky LP; Kahan BD
    Transplantation; 1991 Nov; 52(5):851-7. PubMed ID: 1835196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.